The exclusivity period concludes on 15th jan so hopefully some news on this acquisition/arrangement soon. I'm also expecting an update re Oraline.
They are in the right space in 2014, and with new management, a low market cap, and a bit of cash, SBN has a good shot at creating some serious value from these levels IMO. I reckon howard digby (also director of CYP) could be they key driver now he is executive chairman.
SBN Price at posting:
1.1¢ Sentiment: Buy Disclosure: Held